Clinical Trials Browser

Phase 2 × NIH × halofuginone × Clear all

NCT00064142 2013-06-05

Halofuginone Hydrobromide in Treating Patients With HIV-Related Kaposi's Sarcoma

Phase 2 Completed

AIDS-related Kaposi sarcoma, Sarcoma, Kaposi